TOPLINE: Patients with advanced-stage head and neck squamous cell carcinoma (HNSCC) who were monitored with an intensive post-treatment follow-up strategy using 18F-fludeoxyglucose-positron emission tomography with CT (18F-FDG-PET/CT) […]

New research confirms that chronic immune-related adverse events (AEs) from adjuvant anti-programmable cell death-1 (anti–PD-1) immunotherapy are common, can affect diverse organ systems, and will likely […]